Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence

Current Biology

Volumn 7, Issue 6, 1997, Pages 427-439

  Weeda, G ^a   Donker, I ^a   De Wit, J ^a   Morreau, H ^b   Janssens, R ^a   Vissers, C J ^c   Nigg, A ^c   Van Steeg, H ^d   Bootsma, D ^a   Hoeijmakers, J H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 12644266319     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00190-4     Document Type: Article

References (42)

1. Friedberg EC, Walker GC, Siede W: DNA Repair and Mutagenesis. Washington, DC: ASM Press; 1995.
2. Bootsma D, Cleaver JE, Kraemer KH, Hoeijmakers JHJ: Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. In The Metabolic Basis of Inherited Disease, 8th edn. Edited by Scriver CR, Beaudet AL, Sly WS, Vall D. New York: McGraw-Hill; 1997: in press.
3. Hoeijmakers JHJ: Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies. Eur J Cancer 1994, 30A:1912-1921.
4. Westerveld A, Hoeijmakers JHJ, van Duin M, de Wit J, Odijk H, Pastink A, et al.: Molecular cloning of a human DNA repair gene. Nature 1984, 310:425-429.
5. van Duin M, Vredeveldt G, Mayne L, Odijk H, Vermeulen W, Klein B, et al.: The cloned human DNA excision repair gene ERCC-1 fails to correct xeroderma pigmentosum complementation groups A through I. Mutat Res 1989, 217:83-92.
6. Wood RD: DNA repair in eukaryotes. Annu Rev Biochem 1996, 65:135-167.
7. Sijbers AM, de Laat WJ, Ariza RR, Biggerstaff M, Wei Y-F, Moggs JG, et al.: Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 1996, 86:811-822.
8. Brookman KW, Lamerdin JE, Thelen MP, Hwang M, Reardon JT, Sancar A, et al.: ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs. Mol Cell Biol 1996, 16:6553-6562.
9. van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken MHM, et al.: Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RADIO. Cell 1986, 44:913-923.
10. Bailly V, Sommers CH, Sung P, Prakash L, Prakash S: Specific complex formation between proteins encoded by the yeast DNA repair and recombination genes RAD1 and Rad10. Proc Natl Acad Sci USA 1992, 89:8273-8277.
11. Bardwell L, Cooper AJ, Friedberg EC: Stable and specific association between the yeast recombination and DNA repair proteins RAD1 and RAD10 in vitro. Mol Cell Biol 1992, 12:3041-3049.
12. Fishman-Lobell J, Haber JE: Removal of nonhomologous DNA ends in double-strand break recombination: the role of the yeast ultraviolet repair gene RAD1. Science 1992, 258:480-484.
13. Doolittle RF, Johnson MS, Husain I, Houten B, Thomas DC, Sancar A: Domainal evolution of a prokaryotic DNA repair protein and its relationship to active transport proteins. Nature 1986, 323:351-353.
14. Sijbers AM, van der Spek PJ, Odijk H, van den Berg J, van Duin M, WesterveldA, et al.: Mutational analysis of the human nucleotide excision repair gene ERCC1. Nucleic Acids Res 1996, 24:3370-3380.
15. McWhir J, Selfridge J, Harrison, DJ, Squires S, Melton DW: Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver abnormalities and die before weaning. Nat Genet 1993, 5:217-224.
16. Thomas KR, Capecchi MR: Site-directed mutagenesis by gene-targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
17. van Duin M, van den Tol J, Hoeijmakers JHJ, Bootsma D, Rupp IP, Reynolds P, et al.: Conserved pattern of antisense overlapping transcription in the homologous human ERCC-1 and yeast RADIO DNA repair gene regions. Mol Cell Biol 1989, 9:1794-1798.
18. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501.
19. de Vries A, van Oostrom CTM, Hofhuis FMA, Dornant PM, Berg RJW, de Gruijl FR, et al.: Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA Nature 1995, 377:169-173.
20. Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, Murai H, et al.: High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 1995, 377:165-168.
21. Sands AT, Abuin A, Sanchez A, Conti CJ, Bradley A: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995, 377:162-165.
22. Cheo DL, Meira LB, Hammer RE, Burns DK, Doughty ATB, Friedberg EC: Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr Biol 1996, 6:1691-1694.
23. Johnson JE Jr: Age-related fine structural changes. In Aging and Cell Structure. Edited by Johnson JE Jr. New York: Plenum Press; 1984, 2:37-88.
24. Chaudhary AK, Nokubo M, Ramachandra Reddy G, Yeola SN, Morrow JD, Blair IA, et al.: Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science 1994, 265:1580-1582.
25. Smith JR, Pereira-Smith OM: Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996, 273:63-67.
26. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 1992, 71:587-597.
27. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al.: A p53-dependent mouse spindle checkpoint. Science 1995, 267:1353-1365.
28. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
29. Wu H, Wade M, Krall L, Grisham J, Xiong Y, van Dyke T: Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev 1996, 10:245-260.
30. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991, 352:345-347.
31. Moriwaki S, Nishigori C, Imamura S, Yagi T, Takahashi C, Fukimoto N, et al.: A case of xeroderma pigmentosum complementation group F with neurological abnormalities. Br J Dermatol 1993, 128:91-94.
32. Hayakawa H, Ishizaki K, Inoue M, Yagi T, Sekiguchi M, Takebe H: Repair of ultraviolet radiation damage in xeroderma pigmentosum cells belonging to complementation group F. Mutat Res 1991, 80:381-388.
33. Burns MA, Tomkins DJ: Hypersensitivity to mitomycin C cell killing in Roberts syndrome fibroblasts with, but not without, the heterochromatin abnormality. Mutat Res 1989, 216:243-249.
34. Kunkel TA, Robetts JD, Zakour RA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 1987, 154:367-382.
35. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977, 74:5463-5467.
36. Smith AG, Hooper M: Buffalo rat liver cells produce diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 1987, 121:1-9.
37. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A: Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991, 19:4293.
38. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S: Use of the human elongation factor 1α promoter as a versatile and efficient expression system. Gene 1990, 91:217-223.
39. Vermeulen W, Scott RJ, Rodgers S, Müller HJ, Cole J, Arlett CF, et al.: Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet 1994, 54:191-200.
40. Simpson RJ, Konijn AM, Lombard M, Raja KB, Salisbury JR, Peters, TJ: Tissue iron loading and histopathological changes in hypotransferrinaemic mice. J Pathol 1993, 171:237-244.
41. Cip1 in normal fibroblasts. Genes Dev 1994, 8:3045-3057.
42. Auffray C, Rougeon F: Purification of mouse immunoglobin heavy-chain messenger RNAs from myeloma tumor DNA. Eur J Biochem 1980, 107:303-314.